49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 946 / 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04736953 (ClinicalTrials.gov)	September 1, 2021	4/12/2020	Sirolimus Treatment Of Patients With SLE	Sirolimus Treatment of Patients With Systemic Lupus Erythematosus	Lupus Erythematosus, Systemic	Drug: Sirolimus;Other: Placebo	State University of New York - Upstate Medical University	NULL	Not yet recruiting	18 Years	N/A	All	220	Phase 2	NULL
2	NCT04582136 (ClinicalTrials.gov)	November 2020	3/10/2020	Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus	Efficacy and Safety of Sirolimusin Patients With Active Systemic Lupus Erythematosus Despite Standar ...	Systemic Lupus Erythematosus	Drug: Sirolimus;Drug: Placebo	Chinese SLE Treatment And Research Group	Beijing Municipal Science & Technology Commission;North China Pharmaceutical Group Corporation	Not yet recruiting	18 Years	65 Years	All	146	Phase 2	NULL
3	ChiCTR-IPR-16009451	2016-11-01	2016-10-16	The Efficacy and Safety of Low Dose IL-2 Conbined RapamycinTherapy in Chinese Over-treated Patients ...	The Efficacy and Safety of Low Dose IL-2 Conbined RapamycinTherapy in Chinese Over-treated Patients ...	Systemic Lupus Erythematosus	IL-2group:IL-2;IL-2+ Rapamycingroup :IL-2and Rapamycin;non IL-2or IL-6 antagonist group :Glucocortic ...	the Second Hospital of Shanxi Medical University	NULL	Pending	18	80	Both	IL-2 group:20;IL-2 + Rapamycin group :20;non IL-2 or IL-6 antagonist group :20;		China
4	NCT00779194 (ClinicalTrials.gov)	October 2008	23/10/2008	Prospective Study of Rapamycin for the Treatment of SLE	Prospective Study of Rapamycin for the Treatment of SLE	Systemic Lupus Erythematosus (SLE)	Drug: Rapamycin	State University of New York - Upstate Medical University	Pfizer;Pfizer	Completed	18 Years	N/A	Both	40	Phase 2	United States

First Previous1Next Last